- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03242538
Prehabilitation for Pelvic Cancer: Changes in Setup Variability
September 10, 2019 updated by: Janaki Moni, University of Massachusetts, Worcester
Prehabilitation for Port Films: Phase 1. Evaluating Orthopedic Measurements of Pelvic Tilt During Radiation Treatments for Pelvic Cancer
The investigators hypothesize that two pelvic relaxation exercises will be feasible and safe to perform by subjects daily before radiation during the participant's treatment and will decrease variability of sacral slope measurements on daily port films.
The investigators will observe trends in the daily variability and change in the sacral slope in each participant to determine if this could decrease variability.
The investigators will compare these measurements to a retrospective cohort that did not have the exercises, but did demonstrate variability.
Reducing set-up variability (which inadvertently occurs during radiation) is important to improve radiation targets and diminish potential adverse effects.
The investigators will query participants for objective and subjective feedback on the exercises and record frequency and duration of the two exercises.
Study Overview
Study Type
Interventional
Enrollment (Actual)
9
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01655
- University of Massachusetts Medical School
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients will be >21 yrs of age and will have an oncologic diagnosis that requires a course of pelvic radiation therapy for a minimum of 5 weeks.
- They will have an ECOG Performance Status (This scale, developed by the Eastern Cooperative Oncology Group (ECOG), now part of the ECOG-ACRIN (American College of Radiology Imaging Network) Cancer Research Group, describes a patient's level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.)) of 1 or better as determined by patient history.
- They will be ambulatory without needing any ambulatory aids such as a cane or walker.
- Both men and women will be eligible as there is no significant anatomical difference in sacral slope measurement. Joint replacement patients will not be excluded.
Exclusion Criteria:
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
- Non-English speaking subjects
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pelvic Exercise Intervention
Patients will perform two pelvic exercises prior to each external beam radiation treatment.
|
Hip extension and external hip rotation exercises are completed prior to daily external beam radiation treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sacral Slope Variation
Time Frame: Daily, through duration of radiation treatment, averaging 6-10 weeks
|
Reduced variation in sacral slope angle measured on daily port films.
|
Daily, through duration of radiation treatment, averaging 6-10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jennifer Baima, MD, UMass Medical - Department of Orthopedics
- Principal Investigator: Janaki Moni, MD, UMass Medical - Department of Radiation Oncology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 23, 2017
Primary Completion (Actual)
July 21, 2018
Study Completion (Actual)
January 17, 2019
Study Registration Dates
First Submitted
July 31, 2017
First Submitted That Met QC Criteria
August 3, 2017
First Posted (Actual)
August 8, 2017
Study Record Updates
Last Update Posted (Actual)
September 11, 2019
Last Update Submitted That Met QC Criteria
September 10, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H00013328
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Cancer
-
Institut CurieActive, not recruitingHPV Positive Pelvic CancerFrance
-
Columbia UniversityTerminatedAbdominal Cancer | Pelvic CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingAbdominal Cancer | Pelvic CancerUnited States
-
Baptist Health South FloridaBaptist Health FoundationActive, not recruitingAbdominal Cancer | Pelvic CancerUnited States
-
European Institute of OncologyRecruitingAbdominal Cancer | Pelvic CancerItaly
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruiting
-
Varian, a Siemens Healthineers CompanyActive, not recruitingHead and Neck Cancer | Thoracic Cancer | Abdominal Cancer | Pelvic CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisCompleted
-
Cairo UniversityCompletedPelvic Muscle Strength and FunctionEgypt
-
Assiut UniversityCompletedIntractable Pelvic Cancer PainEgypt
Clinical Trials on Pelvic Exercise
-
Seyda TOPRAK CELENAYUnknown
-
Cairo UniversityNot yet recruitingUrinary Stress Incontinence
-
Cairo UniversityCompleted
-
Selcuk UniversityRecruitingMaternal-Fetal Relations | Pelvic Floor Disorders | Birth, First | Incontinence, UrinaryTurkey (Türkiye)
-
F. D. Roosevelt University HospitalRecruitingRectal Cancer | Pelvic Floor Disorders | Prevention | LARS - Low Anterior Resection Syndrome | Low Anterior ResectionSlovakia
-
Kwong Wah HospitalUnknown
-
Cairo UniversityMansoura UniversityCompletedSleep Deprivation | NocturiaEgypt
-
Chang Gung Memorial HospitalRecruiting
-
Trakya UniversityCompletedMenopause | Stress Urinary Incontinence | Kegel Exercises | Core StrengthTurkey
-
Delta University for Science and TechnologyCompletedPelvic Floor Myofascial PainEgypt